Literature DB >> 7354256

pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena.

H Igimi, M C Carey.   

Abstract

We examined by titration the electrochemical properties, apparent pK (pK'a), precipitation pH, and undissociated bile acid solubilities of chenodeoxycholic acid and its 7 beta epimer, ursodeoxycholic acid and their glycine conjugates as functions of a number of physical-chemical variables. Despite comparable pK'a values, ursodeoxycholic acid and its glycine conjugate precipitated from H2O(37 degrees C) at pH values of 8.0-8.1 and 6.5-7.4 whereas chenodeoxycholic acid and its glycine conjugate precipitated at pH values of 7.0-7.1 and 4.,-5.0, respectively. These differences were related to the low solubility of undissociated ursodeoxycholic acid in water (53 microM) and in ursodeoxycholic micelles (saturation ratio of anion:acid, 90-400:1) compared with the higher solubility of chenodeoxycholic acid in water and in chenodeoxycholate micelles (250 microM and 5-25:1, respectively). In model bile systems including those composed of conjugated ursodeoxycholate-chenodeoxycholate mixtures, ursodeoxycholic acid was less soluble than chenodeoxycholic acid and induced the mixtures to gel between pH 7.0 and 4.5-6.5. These results suggest that in vivo 1) the solubility and absorption of oral ursodeo;ycholic acid from the duodenum-jejunum may be limited, 2) ursodeoxycholic acid will precipitate in the colon at pH values less than 8.0 but chenodeoxycholic acid is soluble at pH values greater than 6.9 and hence is capable of eliciting a secretory diarrhea, 3) the precipitation pH of glycoursodeoxycholic acid, the predominant bile acid in bile during therapy with ursodeoxycholic acid, falls within the physiological range, thus it is poss;ble that this bile acid may short-circuit the entero-hepatic circulation and even precipitate from bile or gut luminal contents as crystals.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7354256

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  22 in total

1.  Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts.

Authors:  M Muraca; E Zanusso; V Cianci; M T Vilei; P Pazzi; M Dalla Libera; S Gamberini
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

2.  Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trial.

Authors:  Y Fukumoto; K Okita; T Kodama; S Matsuda; S Kawamura; K Harima; Y Harada; K Kawaguchi; Y Iida; T Konishi; K Andoh; H Tanaka; T Hanta; T Sekitani; T Takenami; T Yamasaki; S Yamashita; H Fujimura; M Shimada; M Kohzu; K Shigeta; H Shirasawa
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

Review 3.  [Drug dissolution of gallstones in cholecystolithiasis].

Authors:  W Forth
Journal:  Klin Wochenschr       Date:  1985-11-04

Review 4.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

5.  Absence of significant role of bile acids in diarrhea of a heterogeneous group of postcholecystectomy patients.

Authors:  H Fromm; A K Tunuguntla; M Malavolti; C Sherman; S Ceryak
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

6.  A new therapeutic trial of secretin in the treatment of intrahepatic cholestasis.

Authors:  Y Fukumoto; K Okita; M Yasunaga; T Konishi; T Yamasaki; M Ando; H Shirasawa; T Fuji; T Takemoto
Journal:  Gastroenterol Jpn       Date:  1989-06

7.  Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.

Authors:  H Igimi; S Asakawa; D Watanabe; H Shimura
Journal:  Gastroenterol Jpn       Date:  1983-04

8.  Nasal absorption of insulin: enhancement by hydrophobic bile salts.

Authors:  G S Gordon; A C Moses; R D Silver; J S Flier; M C Carey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

9.  Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.

Authors:  S J Longmire-Cook; J Lillienau; Y S Kim; C D Schteingart; R G Danzinger; O Esch; A F Hofmann
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

10.  Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study.

Authors:  U Leuschner; M Leuschner; J Sieratzki; W Kurtz; K Hübner
Journal:  Dig Dis Sci       Date:  1985-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.